Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)

NCT06093269 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT06093269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06093269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)
Lead sponsor
University Hospital, Tours
Phase
Phase 4
Overall status
Active, not recruiting
Start date
November 20, 2023
Completion date
December 31, 2025
Enrollment
32 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis catheter infection, infection, bacterial